Cantel Medical Corporation
CMD
CMD was delisted on the 1st of June, 2021.
155 hedge funds and large institutions have $1.16B invested in Cantel Medical Corporation in 2014 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 59 increasing their positions, 51 reducing their positions, and 9 closing their positions.
33% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 9
16% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 51
1% more funds holding
Funds holding: 154 → 155 (+1)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
6% less capital invested
Capital invested by funds: $1.23B → $1.16B (-$70.2M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $138K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
+$5.91M |
| 2 |
FTIOP
Fiduciary Trust International of Pennsylvania
Radnor,
Pennsylvania
|
+$2.55M |
| 3 |
EARNEST Partners
Atlanta,
Georgia
|
+$2.02M |
| 4 |
O
OppenheimerFunds
New York
|
+$1.71M |
| 5 |
Goldman Sachs
New York
|
+$1.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$2.16M |
| 2 |
KB
Kimelman & Baird
New York
|
-$1.83M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.48M |
| 4 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$1.2M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$948K |
CMD Hedge Fund Activity: Q3 2014 in Review
155 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q3 2014, worth a combined $1.16B — down 5.7% from $1.23B a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new CMD positions and 9 closed out — a net gain of 3 holders — while 59 added to existing stakes and 51 trimmed.
The largest buyer was Conestoga Capital Advisors, adding an estimated $5.91M. The largest seller was Panagora Asset Management, cutting an estimated $2.16M.
- 155 institutional investors held Cantel Medical Corporation (CMD) as of Q3 2014, up from 154 in Q2 2014.
- Funds reported $1.16B of Cantel Medical Corporation stock for Q3 2014, down 5.7% quarter-over-quarter.
- 12 funds opened new Cantel Medical Corporation positions in Q3 2014 and 9 closed out, a net change of +3 holders.
- The largest Cantel Medical Corporation buyer in Q3 2014 was Conestoga Capital Advisors, an estimated $5.91M added.
- The largest Cantel Medical Corporation seller in Q3 2014 was Panagora Asset Management, an estimated $2.16M sold.
Based on aggregated 13F filings for Q3 2014.